Clinuvel scores long-awaited FDA win for skin implant Scenesse by Kyle Blankenship Wednesday, October 9, 2019 It wasn’t so long ago that Clinuvel was targeted by Retrophin and then-CEO Martin Shkreli. One FDA approval later, the company is set for a big leap.
